Early cortical gray matter loss and cognitive correlates in non-demented Parkinson's patients

Parkinsonism and Related Disorders

Volumn 19, Issue 12, 2013, Pages 1088-1093

  Lee, Eun Young ^a   Sen, Suman ^a   Eslinger, Paul J ^a   Wagner, Daymond ^a   Shaffer, Michele L ^a,b   Kong, Lan ^a   Lewis, Mechelle M ^a   Du, Guangwei ^a   Huang, Xuemei ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Cognition; Gray matter volume; MRI; Parkinson's disease; Voxel based morphometry

Indexed keywords

ADULT; ARTICLE; ATTENTION; BRAIN ATROPHY; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; EARLY CORTICAL GRAY MATTER LOSS; EXECUTIVE FUNCTION; FEMALE; FINE MOTOR SPEED; FRONTAL CORTEX; GRAY MATTER; GRAY MATTER REDUCTION; HUMAN; LANGUAGE; MALE; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; NON DEMENTED PARKINSON DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PARIETO-OCCIPITAL SULCUS; PARKINSON DISEASE; PRIORITY JOURNAL; PROCESSING SPEED; SPATIAL COGNITION; SPATIAL MEMORY; STRIATO THALAMO CORTICAL CIRCUITRY DYSFUNCTION; VOXEL BASED MORPHOMETRY;

COGNITION; GRAY MATTER VOLUME; MRI; PARKINSON'S DISEASE; VOXEL-BASED MORPHOMETRY;

CEREBRAL CORTEX; COGNITION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 84889084169     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.07.018     Document Type: Article

References (30)

1. Kehagia A.A., Barker R.A., Robbins T.W. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol 2010, 9:1200-1213.
2. Muslimovic D., Post B., Speelman J.D., Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005, 65:1239-1245.
3. Lewis S.J., Dove A., Robbins T.W., Barker R.A., Owen A.M. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. JNeurosci 2003, 23:6351-6356.
4. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986, 9:357-381.
5. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
6. Pan P.L., Song W., Shang H.F. Voxel-wise meta-analysis of gray matter abnormalities in idiopathic Parkinson's disease. Eur J Neurol 2012, 19:199-206.
7. Pereira J.B., Junque C., Marti M.J., Ramirez-Ruiz B., Bargallo N., Tolosa E. Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease. Mov Disord 2009, 24:1193-1199.
8. Dalaker T.O., Zivadinov R., Larsen J.P., Beyer M.K., Cox J.L., Alves G., et al. Gray matter correlations of cognition in incident Parkinson's disease. Mov Disord 2010, 25:629-633.
9. Scahill R.I., Frost C., Jenkins R., Whitwell J.L., Rossor M.N., Fox N.C. Alongitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 2003, 60:989-994.
10. Gunstad J., Spitznagel M.B., Luyster F., Cohen R.A., Paul R.H. Handedness and cognition across the healthy lifespan. Int J Neurosci 2007, 117:477-485.
11. Calne D., Snow B., Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992, 32:S125-S127.
12. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
13. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010, 25:2649-2653.
14. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. Neuroimage 2000, 11:805-821.
15. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004, 23:S208-S219.
16. Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 2002, 15:1-25.
17. Hamilton M. Arating scale for depression. JNeurol Neurosurg Psychiatr 1960, 23:56-62.
18. Jurica P.J., Leitten C.L., Mattis S. Dementia. Ratings scale-2. Professional manual 2004, Psychological Assessment Resources, Odessa FL.
19. Delis D.C., Kaplan E., Kramer J.H. Delis-kaplan executive function system (D-KEFS) 2001, Psychological Corporation, San Antonio, TX.
20. Wechsler D. WAIS-III: administration and scoring manual: wechsler adult intelligence scale 1997, Psychological Corporation, San Antonio, TX.
21. Kaplan E.F., Goodglass H., Weintraub S. The Boston Naming test 2001, Lippincott Williams & Wilkins, Philadelphia. 2nd ed.
22. Benedict R. Brief visuospatial memory test, revised: professional manual 1997, Psychological Assessment Resources, Odessa, FL.
23. Brandt J., Benedict R. Hopkins verbal learning test, revised: professional manual 2001, Psychological Assessment Resources, Odessa, FL.
24. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. JR Statist Soc Ser B (Methodological) 1995, 289-300.
25. Marchand W.R., Lee J.N., Thatcher J.W., Hsu E.W., Rashkin E., Suchy Y., et al. Putamen coactivation during motor task execution. Neuroreport 2008, 19:957-960.
26. Monchi O., Petrides M., Doyon J., Postuma R.B., Worsley K., Dagher A. Neural bases of set-shifting deficits in Parkinson's disease. JNeurosci 2004, 24:702-710.
27. Ibarretxe-Bilbao N., Junque C., Marti M.J., Tolosa E. Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease. JNeurol Sci 2011, 310:70-74.
28. Smith C.D., Chebrolu H., Wekstein D.R., Schmitt F.A., Markesbery W.R. Age and gender effects on human brain anatomy: a voxel-based morphometric study in healthy elderly. Neurobiol Aging 2007, 28:1075-1087.
29. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 2001, 11:1136-1143.
30. Samuel M., Ceballos-Baumann A., Blin J., Uema T., Boecker H., Passingham R., et al. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain 1997, 120:963-976.